Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.32−0.10 (-7.04%)
Close on Nov 12, 2026Market cap $83.70MP/E –Yield –
Equillium operating margin
Operating margin is operating income as a percentage of revenue.
Equillium's operating margin for the twelve months ending Dec 31, 2024 was -20.1%. For fiscal 2024 it was -20.1%, against -40.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -20.1% | +20.1 |
| FY2023 | Dec 31, 2023 | -40.2% | +353.7 |
| FY2022 | Dec 31, 2022 | -393.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -107.0% | −72.2 |
| Q3 FY2024 | Sep 30, 2024 | -5.6% | +35.3 |
| Q2 FY2024 | Jun 30, 2024 | -0.7% | +38.6 |
| Q1 FY2024 | Mar 31, 2024 | -26.1% | +20.2 |
| Q4 FY2023 | Dec 31, 2023 | -34.7% | – |
| Q3 FY2023 | Sep 30, 2023 | -40.8% | – |
| Q2 FY2023 | Jun 30, 2023 | -39.4% | – |
| Q1 FY2023 | Mar 31, 2023 | -46.3% | – |
See a number that looks wrong?